New therapy potential lifesaver for those intolerant to blood thinners
Wednesday, January 15, 2014 - 13:00
in Health & Medicine
A new, minimally invasive procedure for atrial fibrillation (AF) patients who are intolerant of blood-thinning medications is now available. Atrial fibrillation is a heart disorder that affects nearly 3 million adults in the United States. The procedure, which uses the FDA-approved LARIAT® Suture Delivery Device, provides a permanent, one-time solution to reduce complications surrounding the disorder -- primarily the risk of stroke.